You have Guest access.
Log In
Volume 1 / 1983 - Volume 30 / 2012
1-9
Topic Paper
Mechanisms of the development of androgen independence in prostate cancer
Alan So, Martin Gleave, Antonio Hurtado-Col and Colleen Nelson
10-13
Chemotherapy for androgen-independent prostate cancer
Daniel P. Petrylak
14-18
The role of bisphosphonates in hormone-refractory prostate cancer
Fred Saad, Pierre Karakiewicz and Paul Perrotte
19-27
Endothelin receptor antagonists
Joel B. Nelson
28-32
Rationale for the development and current status of calcitriol in androgen-independent prostate cancer
Tomasz M. Beer, Anne Myrthue and Kristine M. Eilers
33-37
Targeting Bcl-2 with oblimersen for patients with hormone refractory prostate cancer
Kim N. Chi
38-46
Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer
Martin Gleave and Hideaki Miyake
47-49
Immunotherapy with autologous antigen presenting cells for the treatment of androgen independent prostate cancer
Paul F. Schellhammer and Robert M. Hershberg
50-54
Free Paper
Impact of tumor size on the long-term survival of patients with early stage renal cell cancer
M. Kuczyk, G. Wegener, A. S. Merseburger, A. Anastasiadis and S. Machtens, et al.
55-60
Sacral colpopexy using mersilene mesh in the treatment of vaginal vault prolapse
Jerry Limb, Kay Wood, Michael Weinberger, Fred Miyazaki and Sherif Aboseif
61-66
Clinical characterization of the prostatitis patient in Italy: a prospective urology outpatient study
Michelangelo Rizzo, Federico Marchetti, Fabrizio Travaglini, Alberto Trinchieri and J. Curtis Nickel
Frequently asked questions General info on journals and books Send us your feedback Impressum Contact us
© Springer, Part of Springer Science+Business Media Privacy, Disclaimer, Terms & Conditions, and Copyright Info